MarginsXMarginsX
Home › Markets › CASIF

CASI Pharmaceuticals, Inc. (CASIF)

CASIF is quoted over the counter, not listed on an exchange. CASI Pharmaceuticals, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.1000
0.0% on the day
1-year return
-92.1%
Market cap
$2.1M
Nano cap. From the Nov 16, 2026 close × 20.6M shares (20-F cover page, Dec 31, 2025)
P/E and P/S
Net loss over the period · 0.1×
On fiscal year to December 31, 2025 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerCASIF, quoted over the counter
SEC CIK0001962738
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressBeijing, China
Incorporated inCayman Islands

Warning signs

Cash runway
3.3 months
$5.6M cash at December 31, 2025
Share count, 1 year
+32.7%
2024-12-31 to 2025-12-31 · +52.7% over 3 years
Going-concern doubt
Yes
20-F filed May 15, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about our ability to continue as a going concern within a reasonable period of time, which is considered to be one year from the issuance date of the annual report for the year ended December 31, 2025."
20-F 2026-05-15
Cash and burn$5.6M cash; operating cash flow -$5.2M a quarter.Report 2025-12-31
Shares outstanding20,555,873 (2025-12-31); 15,492,581 a year earlier; 13,457,625 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-06-23
AuditorKPMG Huazhen LLP, Beijing, ChinaPCAOB Form AP 2026-06-02
Late filings, 12 months1 NT noticeNT 20-F 2026-04-21
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$20.7M-$48.1M-$20.8M$5.6M$19.2M$20.7M20-F 2026-05-15
FY 2024
2024-12-31
$28.5M-$39.3M-$29.2M$13.5M$18.4M$28.5M20-F 2026-05-15
FY 2023
2023-12-31
$33.9M-$27.0M-$20.0M$17.1M$18.9M$33.9M20-F 2026-05-15
FY 2022
2022-12-31
$43.1M-$41.0M-$21.1M$47.1MNo debt tags$43.1M20-F 2025-03-31
FY 2021
2021-12-31
$30.2M-$36.7M-$26.8M$38.7MNo debt tags$30.2M20-F 2024-03-28
FY 2020
2020-12-31
$15.1M-$48.3M-$25.9MNot filedNo debt tags$15.1M20-F 2023-04-26

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-04-01
Latest annual report20-F2026-05-15
Latest quarterly / interim6-K2026-09-02

Source: SEC EDGAR submissions feed, 157 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier